Valuation Ipca Laboratories Limited Bombay S.E.

Stocks

Market Closed - Bombay S.E. Other stock markets 06:00:50 2026-07-06 EDT			5-day change	1st Jan Change
1,780.35 ^INR	-0.03%		+8.00%	+25.02%

06-26	Ipca Laboratories Limited agreed to acquire remaining 50.35% stake in Krebs Biochemicals & Industries Limited for INR 612 million.	CI
06-01	Ipca Laboratories Limited, Q4 2026 Earnings Call, Jun 01, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	241,495	270,385	205,589	313,934	381,038	452,202	-	-
Change	-	11.96%	-23.96%	52.7%	21.38%	18.68%	-	-
Enterprise Value (EV) ¹	239,835	275,070	201,870	325,349	391,231	408,673	440,378	428,542
Change	-	14.69%	-26.61%	61.17%	20.25%	4.46%	-1.52%	-2.69%
P/E	21.1x	30.6x	43.6x	57.4x	51.6x	35.6x	32.4x	27.2x
PBR	5.14x	4.92x	2.58x	4.96x	5.48x	5.04x	4.82x	4.16x
PEG	-	-1.4x	-0.9x	3.6x	1.5x	0.7x	1.4x	1.4x
Capitalization / Revenue	4.46x	4.64x	3.29x	4.07x	4.26x	4.21x	4.2x	3.76x
EV / Revenue	4.43x	4.72x	3.23x	4.22x	4.38x	4.24x	4.09x	3.56x
EV / EBITDA	15.5x	21x	21.8x	24.6x	22.7x	20.7x	18.7x	15.7x
EV / EBIT	18x	25.6x	30.3x	33.8x	29.5x	26.2x	23.3x	19.4x
EV / FCF	32.9x	72.9x	64.8x	60.9x	71.7x	83.5x	46.4x	39x
FCF Yield	3.04%	1.37%	1.54%	1.64%	1.4%	1.2%	2.16%	2.57%
Dividend per Share ²	4	8	4	4	2	6	5.792	6.258
Rate of return	0.42%	0.75%	0.49%	0.32%	0.13%	0.37%	0.32%	0.35%
EPS ²	45.06	34.85	18.58	21.57	29.08	44.98	55.01	65.63
Distribution rate	8.88%	23%	21.5%	18.5%	6.88%	13.3%	10.5%	9.54%
Net sales ¹	54,200	58,298	62,443	77,050	89,396	96,463	107,715	120,253
EBITDA ¹	15,444	13,073	9,268	13,212	17,261	19,786	23,566	27,242
EBIT ¹	13,352	10,748	6,652	9,639	13,283	15,604	18,929	22,038
Net income ¹	11,400	8,841	4,713	5,474	7,377	11,411	14,004	16,646
Net Debt ¹	-1,660	4,685	-3,720	11,415	10,193	2,442	-11,824	-23,660
Reference price ²	951.88	1,065.75	810.35	1,237.40	1,501.90	1,782.40	1,782.40	1,782.40
Nbr of stocks (in thousands)	253,704	253,704	253,704	253,704	253,704	253,704	-	-
Announcement Date	5/28/21	5/24/22	5/29/23	5/29/24	5/29/25	5/29/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.49x	12.89x	26.26x	0.56%	1,082B
JOHNSON & JOHNSON	28.11x	6.46x	17.57x	2.03%	633B
ABBVIE INC.	32.2x	7.69x	15.73x	2.65%	461B
ROCHE HOLDING AG	18.15x	4.51x	11.08x	2.94%	338B
ASTRAZENECA PLC	24.06x	5.03x	14.1x	1.73%	299B
NOVARTIS AG	22.19x	5.69x	13.74x	2.76%	291B
NOVO NORDISK A/S	14.43x	5.37x	11.03x	3.47%	222B
AMGEN INC.	24.39x	6.45x	11.36x	2.7%	202B
GILEAD SCIENCES, INC.	-46.87x	5.66x	31.47x	2.47%	163B
Average	16.90x	6.64x	16.92x	2.37%	410.27B
Weighted average by Cap.	24.74x	8.04x	18.59x	1.94%